Fund details
Series |
Currency |
Fund code |
MER * (%) |
|---|---|---|---|
| F | CAD | 35096 | 1.04% |
Portfolio analysis As of Aug 31, 2025
99%
1%
Equity
Fixed Income
Asset mix
Equity Sector Allocation
Industrials22.7%
Information Technology19.1%
Health Care17.1%
Consumer Discretionary15.5%
Financials14.1%
Energy3.8%
Materials2.6%
Communication Services2.1%
Consumer Staples2.0%
Real Estate1.0%
Top 10 Holdings |
% Assets |
|---|---|
| Astera Labs Inc | 1.2% |
| Comfort Systems USA Inc | 1.2% |
| Piper Sandler Cos | 1.2% |
| Moelis & Co - Class A Shares | 1.0% |
| Insmed Inc | 1.0% |
| Halozyme Therapeutics Inc | 1.0% |
| Rocket Lab Corp | 1.0% |
| Artisan Partners Asset Management Inc - Class A Shares | 1.0% |
| Exelixis Inc | 0.9% |
| Tapestry Inc | 0.9% |
| Total % of Top 10 Holdings | 10.4% |
Geographic allocation
Region
- United States99.8%
- Europe0.1%
- Latin America0.1%
Performance analysis
Growth of $10,000 since inception
Calendar returns
Trailing return
| 1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
|---|---|---|---|---|---|---|---|---|---|---|
| 1.5 | 8.0 | 16.7 | 3.5 | 12.9 | 7.2 | 6.1 | 3.2 | Fund |
Distribution ($)/unit
| YTD* | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total distributions | --- | --- | --- | --- | 0.62 | --- | --- | 1.26 | 1.52 | --- | 0.10 |
| Interest | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Foreign dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Foreign taxes paid | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Capital gains | --- | --- | --- | --- | 0.62 | --- | --- | 1.26 | 1.52 | --- | 0.10 |
| Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.